Bio-Rad Laboratories (FRA:BUWA) Cyclically Adjusted Book per Share: €240.25 (As of Mar. 2026)


FRA:BUWA Bio-Rad Laboratories Inc FRA:BUWA
72 GF Score
Price €257.60
GF Value €275.94
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bio-Rad Laboratories Cyclically Adjusted Book per Share?

Bio-Rad Laboratories FRA:BUWA -0.39% 72 Cyclically Adjusted Book per Share is €240.25 as of Mar. 2026. GuruFocus rates FRA:BUWA with a GF Score™ of 72/100 and a GF Value™ of €275.94 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was €220.903. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €240.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bio-Rad Laboratories's average Cyclically Adjusted Book Growth Rate was 9.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 16.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bio-Rad Laboratories was 26.60% per year. The lowest was 9.10% per year. And the median was 15.20% per year.

As of today (2026-07-05), Bio-Rad Laboratories's current stock price is €257.60. Bio-Rad Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €240.25. Bio-Rad Laboratories's Cyclically Adjusted PB Ratio of today is 1.07.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Rad Laboratories was 5.80. The lowest was 0.86. And the median was 3.02.


Bio-Rad Laboratories  (FRA:BUWA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bio-Rad Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=257.60/240.25
=1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Rad Laboratories was 5.80. The lowest was 0.86. And the median was 3.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bio-Rad Laboratories Cyclically Adjusted Book per Share Related Terms


Bio-Rad Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Rad Laboratories Cyclically Adjusted Book per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145.81 187.48 204.07 238.60 228.96

Bio-Rad Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 234.44 226.32 218.16 228.96 240.25

FRA:BUWA vs GKOS, BRKR, PODD: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted PB Ratio falls into.


FRA:BUWA
72GF Score
Bio-Rad Laboratories Inc FRA:BUWA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Rad Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Rad Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=220.903/330.2130*330.2130
=220.903

Current CPI (Mar. 2026) = 330.2130.

Bio-Rad Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 79.086 241.018 108.354
201609 81.517 241.428 111.495
201612 82.667 241.432 113.066
201703 85.506 243.801 115.812
201706 84.463 244.955 113.861
201709 80.293 246.819 107.422
201712 83.131 246.524 111.352
201803 122.122 249.554 161.593
201806 133.097 251.989 174.414
201809 140.168 252.439 183.352
201812 118.586 251.233 155.866
201903 144.350 254.202 187.513
201906 162.942 256.143 210.061
201909 155.641 256.759 200.167
201912 173.084 256.974 222.414
202003 192.102 258.115 245.761
202006 220.022 257.797 281.827
202009 251.167 260.280 318.651
202012 272.125 260.474 344.983
202103 299.419 264.877 373.275
202106 323.237 271.696 392.855
202109 435.608 274.310 524.383
202112 404.632 278.802 479.246
202203 308.810 287.504 354.684
202206 284.230 296.311 316.750
202209 286.284 296.808 318.505
202212 306.690 296.797 341.220
202303 307.991 301.836 336.947
202306 268.141 305.109 290.203
202309 270.577 307.789 290.290
202312 281.074 306.746 302.577
202403 291.931 312.332 308.644
202406 223.323 314.175 234.723
202409 240.983 315.301 252.380
202412 223.972 315.605 234.339
202503 223.589 319.799 230.870
202506 228.386 322.561 233.804
202509 212.788 324.800 216.334
202512 235.842 324.054 240.324
202603 220.903 330.213 220.903

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €240.25 mean?
Bio-Rad Laboratories (FRA:BUWA) has a Cyclically Adjusted Book per Share of €240.25 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Rad Laboratories and its competitors.
Is Bio-Rad Laboratories' Cyclically Adjusted Book per Share too high?
Bio-Rad Laboratories' current Cyclically Adjusted Book per Share is €240.25. Overall, Bio-Rad Laboratories has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Rad Laboratories' Cyclically Adjusted Book per Share compare to GKOS and BRKR?
Bio-Rad Laboratories' Cyclically Adjusted Book per Share of €240.25 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Rad Laboratories and its competitors. Bio-Rad Laboratories's current Cyclically Adjusted Book per Share is €240.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Rad Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Bio-Rad Laboratories (FRA:BUWA) is currently considered Fairly Valued. The stock's GF Value™ is €275.94, compared to a current price of €257.60 — trading 6.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is €240.25. Bio-Rad Laboratories' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bio-Rad Laboratories (FRA:BUWA), the current Cyclically Adjusted Book per Share is €240.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Rad Laboratories (FRA:BUWA) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Rad Laboratories stock appears to be undervalued. The current stock price of €257.60 is trading 6.6% below its estimated GF Value™ of €275.94. GuruFocus considers Bio-Rad Laboratories to be Fairly Valued.

Key valuation signals for FRA:BUWA:

  • Cyclically Adjusted Book per Share: €240.25
  • GF Value™: €275.94 vs. price of €257.60 (6.6% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the FRA:BUWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Rad Laboratories Business Description

Address 1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
72GF Score

Get the complete analysis for FRA:BUWA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€257.60
Price
€275.94
GF Value